BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27888350)

  • 21. Patient satisfaction and acceptance of their totally implanted central venous catheter: a French prospective multicenter study.
    Marcy PY; Schiappa R; Ferrero JM; Dahlet C; Brenet O; Yazbec G; Dubois PY; Salm B; Fouche Y; Mari V; Montastruc M; Lebrec N; Ancel B; Paillocher N; Dupoiron D; Rangeard O; Gal J; Ettaiche M; Chateau Y; Chamorey E
    J Vasc Access; 2017 Sep; 18(5):390-395. PubMed ID: 28731491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?
    Jo JE; Tang EY; Pua BB
    Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
    Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
    Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Forty years after the first totally implantable venous access device (TIVAD) implant: the pure surgical cut-down technique only avoids immediate complications that can be fatal.
    Toro A; Schembari E; Fontana EG; Di Saverio S; Di Carlo I
    Langenbecks Arch Surg; 2021 Sep; 406(6):1739-1749. PubMed ID: 34109472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound-guided totally implantable venous access device through the right innominate vein in older patients is safe and reliable.
    Sun X; Zhang Y; Yang C; Zhou Y; Bai X; Zheng W; Jin Y
    Geriatr Gerontol Int; 2019 Mar; 19(3):218-221. PubMed ID: 30724007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multicenter validation study of a questionnaire assessing patient satisfaction with and acceptance of totally-implanted central venous access devices].
    Marcy PY; Dahlet C; Brenet O; Yazbec G; Dubois PY; Salm B; Fouche Y; Mari V; Montastruc M; Lebrec N; Ancel B; Paillocher N; Dupoiron D; Rangeard O; Michel C; Chateau Y; Ettaiche M; Ferrero JM; Chamorey E
    Bull Cancer; 2015 Apr; 102(4):301-15. PubMed ID: 25799876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chinese expert consensus on the nursing management of the totally implantable venous access device.
    Xu Y; Fei XY; Xue YH; Wang XM; Wang XY; Zheng YT; Chen K; He JJ; Ren XH; Pan L; Wang L; Qian D; Li WF; Liang Y; Fang Y; Huang XF; Li CH; Chen DP; Wang Y; Wen LH; Zhang YH; Zheng Y; Song H; Lin YC; Zhang Q; Yang RM; Wang ZM
    J Cancer Res Ther; 2022 Sep; 18(5):1231-1240. PubMed ID: 36204867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complication-related removal of totally implantable venous access port systems: Do not forget the skin scar in survivors!
    Gaucher S; Martin A; Benachour I; Maladry D; Tigaud JM; Goldwasser F; Philippe HJ
    Eur J Surg Oncol; 2017 Apr; 43(4):851-852. PubMed ID: 28148464
    [No Abstract]   [Full Text] [Related]  

  • 29. Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients.
    El-Balat A; Schmeil I; Karn T; Holtrich U; Mavrova-Risteska L; Rody A; Youssef A; Hanker LC
    In Vivo; 2018; 32(5):1275-1281. PubMed ID: 30150457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The trapezius port: a novel approach for port access.
    Copper CM; Pacanowski JP; Bell JL
    Am Surg; 2005 Feb; 71(2):106-9. PubMed ID: 16022007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radio-opacity and incidental identified mechanical complications of totally implantable venous access devices placed in the chest.
    Surov A; Rusner C; Weigand K; John E; Spielmann RP; Behrmann C
    Acta Radiol; 2012 Nov; 53(9):1035-9. PubMed ID: 23028172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial regarding use of modified femoral vein approach as method for implanting a totally implantable access port in patients with synchronous bilateral mastectomies (Chen et al.).
    Wanebo HJ
    J Surg Oncol; 2008 Sep; 98(3):147. PubMed ID: 18704913
    [No Abstract]   [Full Text] [Related]  

  • 33. A totally implantable venous access device (TIVAD) abandoned for 5 years is re-accessed normally: A case report and literature review.
    He J
    J Vasc Access; 2023 May; 24(3):502-506. PubMed ID: 34396820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comparison Between Upper Arm and Chest for Optimal Site of Totally Implanted Venous Access Ports in Patients with Female Breast Cancer.
    Yang SS; Ahn MS
    Ann Vasc Surg; 2018 Jul; 50():128-134. PubMed ID: 29481918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scarless totally implantable venous access port (TIVAP) implantation: Surgical technique, preliminary results, learning curve, and patients-reported outcome in 125 breast cancer patients.
    Chang YL; Sae-Lim C; Lin SL; Lai HW; Huang HI; Lai YC; Chen ST; Chen DR
    Surg Oncol; 2024 Apr; 53():102048. PubMed ID: 38412756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective evaluation on external jugular vein cut-down approach for TIVAD implantation.
    Cavallaro G; Iorio O; Iossa A; De Angelis F; Avallone M; Massaro M; Mattia C; Silecchia G
    World J Surg Oncol; 2015 Aug; 13():243. PubMed ID: 26264364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous
    Matiotti-Neto M; Eskander MF; Tabatabaie O; Kasumova G; Bliss LA; Ng SC; Tawa NE; Murphy B; Critchlow JF; Tseng JF
    Am Surg; 2017 Dec; 83(12):1336-1342. PubMed ID: 29336750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External jugular vein approach for TIVAD implantation: first choice or only an alternative? A review of the literature.
    Iorio O; Cavallaro G
    J Vasc Access; 2015; 16(1):1-4. PubMed ID: 25198827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclavian vein stenosis following totally implantable venous access device (TIVAD) implant by percutaneous approach. Case report.
    Di Carlo I; Fasone MA; Toro A; Castello G; Sparatore F; Cordio S
    G Chir; 2004; 25(11-12):417-9. PubMed ID: 15803820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.